Monte Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
2,872
+127
| +5% | +$51.5K | 0.45% | 62 |
|
|
2025
Q1 | $1.17M | Buy |
2,745
+475
| +21% | +$203K | 0.51% | 55 |
|
|
2024
Q4 | $1.18M | Buy |
2,270
+57
| +3% | +$29.7K | 0.51% | 54 |
|
|
2024
Q3 | $1.37M | Buy |
2,213
+58
| +3% | +$35.9K | 0.57% | 45 |
|
|
2024
Q2 | $1.19M | Buy |
2,155
+61
| +3% | +$33.7K | 0.53% | 52 |
|
|
2024
Q1 | $1.22M | Buy |
2,094
+28
| +1% | +$16.3K | 0.53% | 50 |
|
|
2023
Q4 | $1.1M | Buy |
2,066
+134
| +7% | +$71.1K | 0.51% | 51 |
|
|
2023
Q3 | $978K | Buy |
1,932
+20
| +1% | +$10.1K | 0.49% | 49 |
|
|
2023
Q2 | $998K | Buy |
1,912
+488
| +34% | +$255K | 0.49% | 49 |
|
|
2023
Q1 | $821K | Buy |
1,424
+74
| +5% | +$42.7K | 0.43% | 51 |
|
|
2022
Q4 | $743K | Buy |
1,350
+159
| +13% | +$87.6K | 0.38% | 55 |
|
|
2022
Q3 | $604K | Buy |
1,191
+331
| +38% | +$168K | 0.37% | 54 |
|
|
2022
Q2 | $467K | Buy |
860
+291
| +51% | +$158K | 0.27% | 68 |
|
|
2022
Q1 | $336K | Buy |
+569
| New | +$336K | 0.18% | 71 |
|